Creative Planning’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Creative Planning’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$128	–	3154
2023 Q3	$128	Buy	+100	New	+$87	﹤0.01%	2876
2017 Q3	–	Sell	-871	Closed	-$15K	–	3926
2017 Q2	$15K	Buy	871 +700	+409%	+$13.9K	﹤0.01%	3377
2017 Q1	$3K	Sell	171 -150	-47%	-$2.98K	﹤0.01%	4198
2016 Q4	$5K	Buy	+321	New	+$4.32K	﹤0.01%	3989

Creative Planning's ZYNE Position: Q4 2023 in Review

Creative Planning sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 100 shares — an estimated $128 sold.

Creative Planning first reported a position in ZYNE in Q4 2016 and held it in 4 quarters. The position peaked at $15K in Q2 2017. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

Creative Planning reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Creative Planning sold 100 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $128.
Creative Planning first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2016 and held it in 4 quarters.
Creative Planning's Zynerba Pharmaceuticals, Inc position peaked at $15K in Q2 2017.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Creative Planning's 13F filing for Q4 2023, filed 14 Feb 2024.